The tumor was negative for PD-L1, with low levels of infiltrating T lymphocytes while demonstrating relatively higher numbers of 4-1BB/CD137+ cells and an elevated CD8/FoxP3 ratio (Table 3). The gene discussed is CD8A; the disease is neoplasm.